Levi-Schaffer F - Search Results

1

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.

Carvalho S, Levi-Schaffer F, Sela M, Yarden Y. Carvalho S, et al. Br J Pharmacol. 2016 May;173(9):1407-24. doi: 10.1111/bph.13450. Epub 2016 Mar 14. Br J Pharmacol. 2016. PMID: 26833433 Free PMC article. Review.

2

The expanding role of immunopharmacology: IUPHAR Review 16.

Tiligada E, Ishii M, Riccardi C, Spedding M, Simon HU, Teixeira MM, Cuervo ML, Holgate ST, Levi-Schaffer F. Tiligada E, et al. Br J Pharmacol. 2015 Sep;172(17):4217-27. doi: 10.1111/bph.13219. Epub 2015 Jul 21. Br J Pharmacol. 2015. PMID: 26173913 Free PMC article. Review.

3

Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.

Landolina N, Levi-Schaffer F. Landolina N, et al. Br J Pharmacol. 2016 Mar;173(5):793-803. doi: 10.1111/bph.13396. Epub 2016 Feb 1. Br J Pharmacol. 2016. PMID: 26620589 Free PMC article. Review.

4

Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab.

Cazzola M, Matera MG, Levi-Schaffer F, Rogliani P. Cazzola M, et al. Expert Opin Drug Saf. 2018 Apr;17(4):429-435. doi: 10.1080/14740338.2018.1446940. Epub 2018 Mar 8. Expert Opin Drug Saf. 2018. PMID: 29486600 Review.

5

A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29.

Alexander SPH, Armstrong JF, Davenport AP, Davies JA, Faccenda E, Harding SD, Levi-Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding M. Alexander SPH, et al. Br J Pharmacol. 2020 Nov;177(21):4942-4966. doi: 10.1111/bph.15094. Epub 2020 Jul 19. Br J Pharmacol. 2020. PMID: 32358833 Free PMC article. Review.

6

Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review: 31.

Levi-Schaffer F, de Marco A. Levi-Schaffer F, et al. Br J Pharmacol. 2021 Sep;178(17):3359-3372. doi: 10.1111/bph.15359. Epub 2021 Apr 14. Br J Pharmacol. 2021. PMID: 33401333 Free article. Review.

7

Inhibition of proliferation of psoriatic and healthy fibroblasts in cell culture by selected Dead-sea salts.

Levi-Schaffer F, Shani J, Politi Y, Rubinchik E, Brenner S. Levi-Schaffer F, et al. Pharmacology. 1996 May;52(5):321-8. doi: 10.1159/000139397. Pharmacology. 1996. PMID: 8807676

8

Molecular targets on mast cells and basophils for novel therapies.

Harvima IT, Levi-Schaffer F, Draber P, Friedman S, Polakovicova I, Gibbs BF, Blank U, Nilsson G, Maurer M. Harvima IT, et al. J Allergy Clin Immunol. 2014 Sep;134(3):530-44. doi: 10.1016/j.jaci.2014.03.007. Epub 2014 Apr 24. J Allergy Clin Immunol. 2014. PMID: 24767877 Review.

9

Eosinophils as a pharmacological target for the treatment of allergic diseases.

Landolina NA, Levi-Schaffer F. Landolina NA, et al. Curr Opin Pharmacol. 2014 Aug;17:71-80. doi: 10.1016/j.coph.2014.07.014. Epub 2014 Aug 14. Curr Opin Pharmacol. 2014. PMID: 25128782 Review.

10

Mast cells and eosinophils in allergy: Close friends or just neighbors.

Gangwar RS, Friedman S, Seaf M, Levi-Schaffer F. Gangwar RS, et al. Eur J Pharmacol. 2016 May 5;778:77-83. doi: 10.1016/j.ejphar.2015.10.036. Epub 2015 Oct 23. Eur J Pharmacol. 2016. PMID: 26526347 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page